Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation

被引:287
作者
Yamashita, N
Hoshida, S
Otsu, K
Asahi, M
Kuzuya, T
Hori, M
机构
[1] Osaka Rosai Hosp, Div Cardiovasc, Sakai, Osaka 5918025, Japan
[2] Osaka Univ, Sch Med, Dept Med 1, Div Cardiol, Suita, Osaka 5650871, Japan
关键词
free radical; tumor necrosis factor; interleukin; 1; infarct size; N-2-mercaptopropionyl glycine;
D O I
10.1084/jem.189.11.1699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epidemiologic investigations have shown that exercise reduces morbidity and mortality from coronary artery disease. In this study, using a rat model, we attempted to determine whether exercise can reduce ischemic injury to the heart and elucidate a mechanism for the cardioprotective effect of exercise. Results showed that exercise significantly reduced the magnitude of a myocardial infarction in biphasic manner. The time course for cardioprotection resembled that of the change in manganese superoxide dismutase (Mn-SOD) activity. The administration of the antisense oligodeoxyribonucleotide to Mn-SOD abolished the expected decrease in infarct size. We showed that the level of tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) increased after exercise. The simultaneous administration of the neutralizing antibodies to the cytokines abolished the exercise-induced cardioprotection and the activation of Mn-SOD. Furthermore, TNF-alpha can mimic the biphasic pattern of cardioprotection and activation of Mn-SOD. An antioxidant completely abolished cardioprotection and the activation of Mn-SOD by exercise or the injection of TNF-alpha as well as exercise-induced increase in TNF-a! and IL-1 beta. The production of reactive oxygen species and endogenous TNF-alpha and IL-1 beta induced by exercise leads to the activation of Mn-SOD, which plays major roles in the acquisition of biphasic cardioprotection against ischemia/reperfusion injury in rats.
引用
收藏
页码:1699 / 1706
页数:8
相关论文
共 48 条
[1]   REDOX REGULATION OF FOS AND JUN DNA-BINDING ACTIVITY INVITRO [J].
ABATE, C ;
PATEL, L ;
RAUSCHER, FJ ;
CURRAN, T .
SCIENCE, 1990, 249 (4973) :1157-1161
[2]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]  
BIJNEN FCH, 1994, B WORLD HEALTH ORGAN, V72, P1
[4]   EFFECTS OF EXERCISE ON COLLATERAL DEVELOPMENT IN MYOCARDIAL ISCHEMIA IN PIGS [J].
BLOOR, CM ;
WHITE, FC ;
SANDERS, TM .
JOURNAL OF APPLIED PHYSIOLOGY, 1984, 56 (03) :656-665
[5]   INTERLEUKIN-1 PRETREATMENT DECREASES ISCHEMIA REPERFUSION INJURY [J].
BROWN, JM ;
WHITE, CW ;
TERADA, LS ;
GROSSO, MA ;
SHANLEY, PF ;
MULVIN, DW ;
BANERJEE, A ;
WHITMAN, GJR ;
HARKEN, AH ;
REPINE, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5026-5030
[6]   A REDOX-BASED MECHANISM FOR CARDIOPROTECTION INDUCED BY ISCHEMIC PRECONDITIONING IN PERFUSED RAT-HEART [J].
CHEN, W ;
GABEL, S ;
STEENBERGEN, C ;
MURPHY, E .
CIRCULATION RESEARCH, 1995, 77 (02) :424-429
[7]   TUMOR-NECROSIS-FACTOR-ALPHA PRETREATMENT IS PROTECTIVE IN A RAT MODEL OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY [J].
EDDY, LJ ;
GOEDDEL, DV ;
WONG, GHW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1056-1059
[8]   INVOLVEMENT OF REACTIVE OXYGEN INTERMEDIATES IN CYCLOOXYGENASE-2 EXPRESSION INDUCED BY INTERLEUKIN-1, TUMOR-NECROSIS-FACTOR-ALPHA, AND LIPOPOLYSACCHARIDE [J].
FENG, L ;
XIA, YY ;
GARCIA, GE ;
HWANG, D ;
WILSON, CB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1669-1675
[9]   STATEMENT ON EXERCISE - BENEFITS AND RECOMMENDATIONS FOR PHYSICAL-ACTIVITY PROGRAMS FOR ALL AMERICANS - A STATEMENT FOR HEALTH-PROFESSIONALS BY THE COMMITTEE ON EXERCISE AND CARDIAC REHABILITATION OF THE COUNCIL ON CLINICAL CARDIOLOGY, AMERICAN-HEART-ASSOCIATION [J].
FLETCHER, GF ;
BLAIR, SN ;
BLUMENTHAL, J ;
CASPERSEN, C ;
CHAITMAN, B ;
EPSTEIN, S ;
FALLS, H ;
FROELICHER, ESS ;
FROELICHER, VF ;
PINA, IL .
CIRCULATION, 1992, 86 (01) :340-344
[10]   REGULATION OF HIV-1 GENE-EXPRESSION [J].
GREENE, WC .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :453-475